Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Sign Up to like & getrecommendations! Published in 2018 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-018-0149-3
Abstract: IntroductionTo investigate treatment outcomes after switching from ranibizumab to aflibercept intravitreal injections in patients with macular oedema (MO) secondary to branch retinal vein occlusion (BRVO).MethodsEligible patients with refractory MO secondary to BRVO, post treatment with… read more here.
Keywords: oedema secondary; branch retinal; treatment; macular oedema ... See more keywords
Comparison between anti‐VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta‐analysis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.12551
Abstract: Therapeutic effects of anti‐VEGF agents, corticosteroids and laser therapy have been previously examined for treating macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). However, anti‐VEGF efficacy has not been previously… read more here.
Keywords: anti vegf; oedema secondary; macular oedema; laser therapy ... See more keywords
Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15010059
Abstract: The aim of this study was to evaluate the efficacy of a treat-and-extend (T&E) regimen of ranibizumab as the first-choice treatment in macular oedema (MO) secondary to branch retinal vein occlusion (BRVO). We conducted a… read more here.
Keywords: macular oedema; regimen ranibizumab; extend regimen; oedema secondary ... See more keywords